The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Catalyst Trusteeship Ltd, acting as Debenture Trustee, has disclosed the creation of a pledge over 64,00,000 equity shares (5.59%) of Onesource Specialty Pharma Ltd by Tenshi Pharmaceuticals Pvt Ltd, a promoter-group entity that holds 2,05,24,714 shares (17.92%) in the company. The pledge was created on January 5, 2026 as security for zero-coupon, secured, unlisted, redeemable non-convertible debentures of up to ₹1,000 crore being issued by Karuna Ventures Pvt Ltd, another group company of the pledgor. The disclosure is filed under Regulation 29(1) of the SEBI Takeover Code, and no shares have actually changed hands — this is purely an encumbrance (pledge) event. The total share capital of the company remains 11,45,25,216 equity shares of ₹1 each.
This is a pledge creation, not a sale or change in ownership, so there is no immediate impact on shareholding pattern or voting rights. However, it signals that the promoter group is raising significant debt (up to ₹1,000 crore) by pledging their shares, which investors should monitor as higher pledge levels can be a risk indicator if share prices decline.